Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type

This publication has 17 references indexed in Scilit:

• Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct Dementia
  Pharmacopsychiatry, 1996
• Hydrogen peroxide mediates amyloid β protein toxicity
  Cell, 1994
• The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigation
  Human Psychopharmacology: Clinical and Experimental, 1994
• A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group
  Published by American Medical Association (AMA) ,1994
• UV-C irradiation-induced peroxidative degradation of microsomal fatty acids and proteins: Protection by an extract of Ginkgo biloba (EGn 761)
  Free Radical Biology & Medicine, 1992
• Proof of Efficacy of Nootropics for the Indication "Dementia" (Phase III) - Recommendations*
  Pharmacopsychiatry, 1992
• Topography of the quantitative electroencephalogram in dementia of the alzheimer type: Relation to severity of dementia
  Psychiatry Research: Neuroimaging, 1991
• Superoxide anion scavenging effect and superoxide dismutase activity ofGinkgo biloba extract
  Cellular and Molecular Life Sciences, 1989
• Sample Size Determination for Some Common Nonparametric Tests
  Journal of the American Statistical Association, 1987
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984